China New Cosmetic Regulations Review: What It Means for Beauty Brands

Since the Cosmetic Supervision and Administration Regulation (CSAR, 化妆品监督管理条例, huàzhuāngpǐn jiāndū guǎnlǐ tiáolì) took effect on May 1, 2021, the average registration timeline for imported general (non-special-use) cosmetics has dropped from 12 months to just 4 months — a 67% reduction. This single reform has reshaped the compliance landscape for beauty brands entering China, replacing a one-size-fits-all approval system with a risk-tiered model. For foreign beauty executives, this review breaks down what the new rules actually change, what still requires caution, and how to build a compliant market entry strategy in 2025.

1. The 2021 CSAR Framework: A Risk-Based Overhaul

The CSAR replaced the 30-year-old 1990 Cosmetic Hygiene Supervision Regulation with a modern, science-driven system. Under the old regime, all imported cosmetics required a lengthy approval from the National Medical Products Administration (NMPA), regardless of risk. Today, the CSAR divides products into two categories that determine your compliance path:

• Special-use cosmetics (防晒, sunscreen, fángshài; 染发, hair dye, rǎnfà; 美白, whitening, měibái; depilatories, anti-hair loss, and others) require full NMPA registration — still a 6–12 month process.
• General cosmetics (moisturizers, cleansers, makeup base products, serums) require only filing and notification, not pre-market approval. This cut the timeline to 3–6 months and, for many low-risk products, to as little as 8 weeks.

Another major structural change: the introduction of the “cosmetic registrant” (化妆品注册人, huàzhuāngpǐn zhùcè rén). Every product must have a legal registrant entity in China — either your own 外商独资企业 (WFOE, wàishāng dúzī qǐyè) subsidiary or a contract registrant. This entity bears full legal liability for safety, efficacy claims, and post-market surveillance. Brands can no longer rely on importers to “handle compliance” — the registrant is liable, and that liability is non-transferable.

The CSAR also mandated Good Manufacturing Practice (GMP) certification for all cosmetic factories supplying the China market, foreign and domestic. As of 2023, NMPA has conducted on-site inspections of 48 overseas cosmetic manufacturing facilities, issuing warnings or suspension notices to 11 (23%). Compliance with China GMP is now a gatekeeping requirement for initial registration.

2. Key Changes for Imported Beauty Brands

Three regulatory shifts have the deepest impact on foreign beauty companies:

2.1 Efficacy Claim Substantiation (功效宣称, gōngxiào xuānchēng)

Under the old system, brands could make general claims like “hydrating” or “brightening” without formal proof. The CSAR changed that. Every claim on a product label — including “moisturizing,” “soothing,” “anti-aging,” “pore-minimizing” — must now be supported by scientific evidence. The NMPA published the Technical Guidelines for Efficacy Claim Evaluation in April 2021, which outlines four tiers of evidence:

2.2 Animal Testing: The Partial Phase-Out

The CSAR introduced a partial exemption from animal testing for imported general cosmetics. From May 1, 2021, general cosmetics with a “compliant dossier” (full safety assessment, stability data, microbiological tests, and third-party non-animal alternative tests) can bypass the previous mandatory rabbit and guinea pig tests. This was a major win for cruelty-free brands — but with three important caveats:

• Special-use cosmetics still require animal testing. Sunscreens, whitening products, and anti-hair loss products must undergo standard animal testing before registration. No exceptions.
• The exemption applies only to “ordinary” (general) cosmetics. If your product makes any claim that could elevate it to special-use (e.g., “SPF 15”), animal testing is required.
• Post-market surveillance can still mandate animal testing. If NMPA finds a safety signal — an adverse reaction or a contamination incident — regulators can require additional animal tests even for previously exempt products.

2.3 New Cosmetic Ingredient Registration

If your product contains an ingredient never registered in China, the CSAR now provides two paths. For ingredients with “national standard” or “existing cosmetic ingredient” (2015 Inventory), registration takes 2–3 months. For truly new ingredients (not on the inventory), you must file a New Cosmetic Ingredient Notification, which requires:

• Full toxicological profile (oral, dermal, inhalation)
• Stability data under China-specific conditions
• Production process description and quality control specs
• Risk assessment for target populations (including pregnant women and children if relevant)

As of December 2024, NMPA had approved only 47 new cosmetic ingredients under the new regime — compared to over 20,000 active ingredient notifications in the EU in the same period. The process takes 12–18 months and costs an estimated RMB 1.5–3 million per ingredient. This is a barrier for independent brands with novel botanical or biotech actives.

3. Efficacy Claim Requirements: What You Must Prove

Efficacy claim substantiation is the most common source of NMPA rejection for imported cosmetics. The NMPA technical guideline defines 8 claim categories, each with specific evidence requirements. For beauty brands, the three most relevant are:

3.1 Moisturizing Claims

Requires either a corneometer measurement (skin hydration increase of ≥10%) or a consumer self-assessment study (≥30 subjects, ≥80% agreement). The study must be conducted in a controlled environment (20–22°C, 40–60% relative humidity). Brands that submitted on-site humidity data (e.g., from humid Beijing) were rejected because the conditions didn’t meet standard parameters. Fix: Use a third-party lab in China (e.g., SGS Shanghai or Intertek Guangzhou) that follows NMPA standard protocols.

3.2 Anti-Aging / Wrinkle Reduction Claims

Requires a 4-week clinical trial with at least 30 subjects, using standardized photography (VISIA or equivalent) and blinded investigator assessment. The study must show a statistically significant reduction (p < 0.05) of at least one wrinkle parameter. Pitfall: One luxury brand submitted European clinical data with a “2-week” duration — NMPA rejected it because China requires a minimum 4-week study for anti-aging claims. Cost: RMB 300,000 (repeat clinical trial in China + re-submission fees). Fix: Always design clinical studies to China’s minimum duration guidelines from the outset.

3.3 Soothing / Anti-Irritation Claims

Requires either a Lactic Acid Sting Test (LAST) or a DNFB-induced irritation model. The test must use Chinese standard subject criteria (Fitzpatrick skin types II–IV, with specific inclusion/exclusion criteria). Brands that used general dermatology populations without China-specific skin types were rejected. Fix: Partner with a Chinese clinical research organization (CRO) experienced in NMPA cosmetic claims studies.

4. Decision Framework for Market Entry

Based on the CSAR risk-tiered structure, here is a clear decision framework:

• If your product is a general cosmetic (moisturizer, cleanser, serum without sunscreen/whitening claims) and all ingredients are on the 2015 Inventory, choose the Filing (General Cosmetic Notification) path. Expect 3–4 months, no animal testing, and full efficacy claim dossiers prepared in advance.
• If your product is a general cosmetic but contains one new ingredient, choose a Two-Phase Strategy: Phase 1 — file the base product without the new ingredient (use a close substitute) to establish brand presence; Phase 2 — file the new ingredient separately (12–18 months). This avoids a full market entry delay.
• If your product is special-use (sunscreen, whitening, hair dye) or makes a claim that touches special-use territory, choose a Full Registration (Special Cosmetic Path). Budget 8–12 months, allocate RMB 500,000–1 million for registration and testing, and accept mandatory animal testing.
• If your brand is a “clean beauty” / “cruelty-free” small batch brand, choose a Registered Agent + Limited SKU Launch. Start with 1–3 general cosmetic SKUs. Use a contract manufacturing partner in China (to control ingredient sourcing) and avoid special-use claims. This keeps cost under RMB 200,000 per SKU and timeline under 5 months.

5. 3 Pitfalls to Avoid — Real Cases

6. Timeline Comparison: Pre-CSAR vs. Post-CSAR

7. Practical Compliance Checklist for 2025

Based on the CSAR implementation experience over the past four years, here is a short checklist every beauty brand should complete before submitting any cosmetic notification or registration:

• ✅ Registrant entity established in China (WFOE or contract registrant). Cannot be an importer or distributor.
• ✅ Ingredient list cross-referenced against the 2015 Inventory and all updates. Flag any “new” ingredients early.
• ✅ Efficacy claim evidence dossier prepared per NMPA technical guidelines. Match each claim to the correct evidence tier.
• ✅ Chinese label reviewed by a regulatory specialist — not just a translator — for accurate claims, mandatory text, and warnings.
• ✅ GMP certification of the manufacturing facility (or a signed declaration with supporting audit documents).
• ✅ Post-market surveillance plan in place: a designated contact person, a mechanism for collecting adverse reactions, and a reporting protocol to NMPA within 30 days.
• ✅ Annual report commitment for each registered product by March 31 of each year. Missing this triggers suspension.

NEXT STEPS

1. Conduct a full regulatory audit. Review your top 5 SKUs against the CSAR efficacy requirements. Identify any claim that needs new clinical data. Read our Efficacy Claim Compliance Guide for Beauty Brands for a step-by-step checklist.
2. Choose your registration path. Decide between WFOE-owned registrant or a contract registrant partner. For small SKU counts, a contract registrant can be 40–60% cheaper. Compare options in our Market Entry Paths for Foreign Beauty Brands.
3. Start the ingredient inventory check today. If any ingredient is not on the 2015 Inventory, budget at least an extra 12 months and RMB 1.5 million for new ingredient registration. Plan your launch around existing ingredients first, then add novel actives later. See our New Cosmetic Ingredient Registration in China for the full breakdown.

— China Gateway 360 —
Remote China market entry support, built around execution.